Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrence Free Survival”

102 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 102 results

Not applicableStudy completedNCT02385604
What this trial is testing

The Predictive Value of CT-PET in Esophageal Cancer

Who this might be right for
Esophageal Neoplasms
St. James's Hospital, Ireland 250
Large-scale testing (Phase 3)UnknownNCT01936233
What this trial is testing

Clinical Study of Antiviral and Aspirin Treatment in Liver Cancer After Radical Surgery

Who this might be right for
Hepatocellular CarcinomaRecurrence
Fudan University 112
Not applicableUnknownNCT02081547
What this trial is testing

IPC Status as a Surgical Quality Marker in Rectal Cancer Surgery

Who this might be right for
Rectal Cancer
Uppsala University 50
Post-approval studies (Phase 4)UnknownNCT05229809
What this trial is testing

Clinical Trial of Yiqi Wenyang Jiedu Prescription in the Prevention and Treatment of Postoperative Metastasis and Recurrence of Gastric Cancer

Who this might be right for
Gastric Carcinoma
Jie Li 212
Large-scale testing (Phase 3)Looking for participantsNCT02064673
What this trial is testing

Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy

Who this might be right for
Prostate Cancer
yair lotan 608
Large-scale testing (Phase 3)Looking for participantsNCT06952803
What this trial is testing

Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

Who this might be right for
Prostate Cancer
AstraZeneca 700
Testing effectiveness (Phase 2)WithdrawnNCT01174537
What this trial is testing

New Castle Disease Virus (NDV) in Glioblastoma Multiforme (GBM), Sarcoma and Neuroblastoma

Who this might be right for
GlioblastomaSarcomaNeuroblastoma
Hadassah Medical Organization
Not applicableEnded earlyNCT00546065
What this trial is testing

APE-Study: Ablation of Barrett's Mucosa vs. Surveillance Without Ablation in Patients Cured From Barrett's Cancer Combined With Randomization of Esomeprazole vs. Placebo for Symptomatic Reflux Control After Successful Barrett's Ablation

Who this might be right for
Barrett's Esophagus
HSK Wiesbaden 68
Not applicableStudy completedNCT00897533
What this trial is testing

Development of a Model to Predict Progression-Free Survival After Erlotinib in Patients With Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
ECOG-ACRIN Cancer Research Group 137
Testing effectiveness (Phase 2)UnknownNCT04664244
What this trial is testing

Combination of Nimotuzumab and Radiotherapy for Recurrent Uterine Cervical Squamous Carcinoma

Who this might be right for
Recurrent Cervical CarcinomaRadiotherapyEpidermal Growth Factor Receptor+4 more
Lei Li 43
Large-scale testing (Phase 3)UnknownNCT00777244
What this trial is testing

Efficacy of Adjuvant Mitotane Treatment (ADIUVO)

Who this might be right for
Adrenocortical Carcinoma
University of Turin, Italy 200
Testing effectiveness (Phase 2)Study completedNCT03801915
What this trial is testing

Perioperative MVT-5873, a Fully Human Monoclonal Antibody Against a CA 19-9 Epitope, for Operable CA 19-9 Producing Pancreatic Cancers, Cholangiocarcinomas, and Metastatic Colorectal Cancers

Who this might be right for
Colon CancerPancreatic CancerCholangiocarcinoma+2 more
National Cancer Institute (NCI) 10
Large-scale testing (Phase 3)Looking for participantsNCT04242017
What this trial is testing

Long-term Better Than Short-term ADT With Salvage RT

Who this might be right for
Prostate Cancer
Universitaire Ziekenhuizen KU Leuven 394
Not applicableUnknownNCT06096493
What this trial is testing

Prognostic Factors Affecting Recurrence and Disease-Free Survival After Surgical Resection for Cancer Rectum

Who this might be right for
Rectal Cancer
South Valley University 200
Large-scale testing (Phase 3)Study completedNCT00883779
What this trial is testing

Tarceva (Erlotinib) or Placebo in Combination With Platinum-Based Therapy as First Line Treatment in Patients With Advanced or Recurrent Non-Small Cell Lung Cancer

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer
Hoffmann-La Roche 451
Testing effectiveness (Phase 2)Looking for participantsNCT06532539
What this trial is testing

Cadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial Carcinoma

Who this might be right for
Endometrial NeoplasmsNeoplasm Recurrence, LocalNeoplasm Metastasis
Shandong Cancer Hospital and Institute 30
Not applicableUnknownNCT02140034
What this trial is testing

Extensive Peritoneal Lavage After Curative Gastrectomy for Gastric Cancer: A Randomised Controlled Trial

Who this might be right for
Gastric Cancer
National University Hospital, Singapore 600
Not applicableLooking for participantsNCT06851988
What this trial is testing

Can Exercise Ameliorate Immunosenescence and Thereby Reduce Relapse in Head and Neck Cancer Patients

Who this might be right for
AgingHigh-intensity Interval TrainingHead and Neck Cancers - Tonsils
Chang Gung Memorial Hospital 180
Large-scale testing (Phase 3)Study completedNCT00806923
What this trial is testing

Avastin (Bevacizumab) in Patients With Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer
Hoffmann-La Roche 1,044
Not applicableStudy completedNCT02135523
What this trial is testing

The Efficacy of Involved-field Radiation Therapy for Residual or Locoregionally Recurrent Epithelial Ovarian Cancer After Definitive Treatment; Multi-institutional Clinical Trial

Who this might be right for
Ovarian Cancer (Epithelial)
Yonsei University 26
Load More Results